Cargando…
The Clinical Performance of an Office-Based Risk Scoring System for Fatal Cardiovascular Diseases in North-East of Iran
BACKGROUND: Cardiovascular diseases (CVD) are becoming major causes of death in developing countries. Risk scoring systems for CVD are needed to prioritize allocation of limited resources. Most of these risk score algorithms have been based on a long array of risk factors including blood markers of...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444120/ https://www.ncbi.nlm.nih.gov/pubmed/26011607 http://dx.doi.org/10.1371/journal.pone.0126779 |
_version_ | 1782373086221303808 |
---|---|
author | Sepanlou, Sadaf G. Malekzadeh, Reza Poustchi, Hossein Sharafkhah, Maryam Ghodsi, Saeed Malekzadeh, Fatemeh Etemadi, Arash Pourshams, Akram Pharoah, Paul D. Abnet, Christian C. Brennan, Paul Boffetta, Paolo Dawsey, Sanford M. Kamangar, Farin |
author_facet | Sepanlou, Sadaf G. Malekzadeh, Reza Poustchi, Hossein Sharafkhah, Maryam Ghodsi, Saeed Malekzadeh, Fatemeh Etemadi, Arash Pourshams, Akram Pharoah, Paul D. Abnet, Christian C. Brennan, Paul Boffetta, Paolo Dawsey, Sanford M. Kamangar, Farin |
author_sort | Sepanlou, Sadaf G. |
collection | PubMed |
description | BACKGROUND: Cardiovascular diseases (CVD) are becoming major causes of death in developing countries. Risk scoring systems for CVD are needed to prioritize allocation of limited resources. Most of these risk score algorithms have been based on a long array of risk factors including blood markers of lipids. However, risk scoring systems that solely use office-based data, not including laboratory markers, may be advantageous. In the current analysis, we validated the office-based Framingham risk scoring system in Iran. METHODS: The study used data from the Golestan Cohort in North-East of Iran. The following risk factors were used in the development of the risk scoring method: sex, age, body mass index, systolic blood pressure, hypertension treatment, current smoking, and diabetes. Cardiovascular risk functions for prediction of 10-year risk of fatal CVDs were developed. RESULTS: A total of 46,674 participants free of CVD at baseline were included. Predictive value of estimated risks was examined. The resulting Area Under the ROC Curve (AUC) was 0.774 (95% CI: 0.762-0.787) in all participants, 0.772 (95% CI: 0.753-0.791) in women, and 0.763 (95% CI: 0.747-0.779) in men. AUC was higher in urban areas (0.790, 95% CI: 0.766-0.815). The predicted and observed risks of fatal CVD were similar in women. However, in men, predicted probabilities were higher than observed. CONCLUSION: The AUC in the current study is comparable to results of previous studies while lipid profile was replaced by body mass index to develop an office-based scoring system. This scoring algorithm is capable of discriminating individuals at high risk versus low risk of fatal CVD. |
format | Online Article Text |
id | pubmed-4444120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-44441202015-06-16 The Clinical Performance of an Office-Based Risk Scoring System for Fatal Cardiovascular Diseases in North-East of Iran Sepanlou, Sadaf G. Malekzadeh, Reza Poustchi, Hossein Sharafkhah, Maryam Ghodsi, Saeed Malekzadeh, Fatemeh Etemadi, Arash Pourshams, Akram Pharoah, Paul D. Abnet, Christian C. Brennan, Paul Boffetta, Paolo Dawsey, Sanford M. Kamangar, Farin PLoS One Research Article BACKGROUND: Cardiovascular diseases (CVD) are becoming major causes of death in developing countries. Risk scoring systems for CVD are needed to prioritize allocation of limited resources. Most of these risk score algorithms have been based on a long array of risk factors including blood markers of lipids. However, risk scoring systems that solely use office-based data, not including laboratory markers, may be advantageous. In the current analysis, we validated the office-based Framingham risk scoring system in Iran. METHODS: The study used data from the Golestan Cohort in North-East of Iran. The following risk factors were used in the development of the risk scoring method: sex, age, body mass index, systolic blood pressure, hypertension treatment, current smoking, and diabetes. Cardiovascular risk functions for prediction of 10-year risk of fatal CVDs were developed. RESULTS: A total of 46,674 participants free of CVD at baseline were included. Predictive value of estimated risks was examined. The resulting Area Under the ROC Curve (AUC) was 0.774 (95% CI: 0.762-0.787) in all participants, 0.772 (95% CI: 0.753-0.791) in women, and 0.763 (95% CI: 0.747-0.779) in men. AUC was higher in urban areas (0.790, 95% CI: 0.766-0.815). The predicted and observed risks of fatal CVD were similar in women. However, in men, predicted probabilities were higher than observed. CONCLUSION: The AUC in the current study is comparable to results of previous studies while lipid profile was replaced by body mass index to develop an office-based scoring system. This scoring algorithm is capable of discriminating individuals at high risk versus low risk of fatal CVD. Public Library of Science 2015-05-26 /pmc/articles/PMC4444120/ /pubmed/26011607 http://dx.doi.org/10.1371/journal.pone.0126779 Text en © 2015 Sepanlou et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Sepanlou, Sadaf G. Malekzadeh, Reza Poustchi, Hossein Sharafkhah, Maryam Ghodsi, Saeed Malekzadeh, Fatemeh Etemadi, Arash Pourshams, Akram Pharoah, Paul D. Abnet, Christian C. Brennan, Paul Boffetta, Paolo Dawsey, Sanford M. Kamangar, Farin The Clinical Performance of an Office-Based Risk Scoring System for Fatal Cardiovascular Diseases in North-East of Iran |
title | The Clinical Performance of an Office-Based Risk Scoring System for Fatal Cardiovascular Diseases in North-East of Iran |
title_full | The Clinical Performance of an Office-Based Risk Scoring System for Fatal Cardiovascular Diseases in North-East of Iran |
title_fullStr | The Clinical Performance of an Office-Based Risk Scoring System for Fatal Cardiovascular Diseases in North-East of Iran |
title_full_unstemmed | The Clinical Performance of an Office-Based Risk Scoring System for Fatal Cardiovascular Diseases in North-East of Iran |
title_short | The Clinical Performance of an Office-Based Risk Scoring System for Fatal Cardiovascular Diseases in North-East of Iran |
title_sort | clinical performance of an office-based risk scoring system for fatal cardiovascular diseases in north-east of iran |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444120/ https://www.ncbi.nlm.nih.gov/pubmed/26011607 http://dx.doi.org/10.1371/journal.pone.0126779 |
work_keys_str_mv | AT sepanlousadafg theclinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT malekzadehreza theclinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT poustchihossein theclinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT sharafkhahmaryam theclinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT ghodsisaeed theclinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT malekzadehfatemeh theclinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT etemadiarash theclinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT pourshamsakram theclinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT pharoahpauld theclinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT abnetchristianc theclinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT brennanpaul theclinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT boffettapaolo theclinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT dawseysanfordm theclinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT kamangarfarin theclinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT sepanlousadafg clinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT malekzadehreza clinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT poustchihossein clinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT sharafkhahmaryam clinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT ghodsisaeed clinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT malekzadehfatemeh clinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT etemadiarash clinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT pourshamsakram clinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT pharoahpauld clinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT abnetchristianc clinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT brennanpaul clinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT boffettapaolo clinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT dawseysanfordm clinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran AT kamangarfarin clinicalperformanceofanofficebasedriskscoringsystemforfatalcardiovasculardiseasesinnortheastofiran |